|
|||||
|
|

Manufacturing services provider Proto Labs (NYSE:PRLB) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.1% year on year to $136.5 million. Guidance for next quarter’s revenue was better than expected at $134 million at the midpoint, 1.8% above analysts’ estimates. Its non-GAAP profit of $0.44 per share was 27.9% above analysts’ consensus estimates.
Is now the time to buy PRLB? Find out in our full research report (it’s free for active Edge members).
Proto Labs delivered a positive fourth quarter, highlighted by double-digit revenue growth and a significant improvement in operating margin. Management attributed the strong performance to robust demand in CNC machining and sheet metal, particularly from high-growth sectors such as aerospace, defense, robotics, and data centers. CEO Suresh Krishna emphasized, "The results this quarter are an early indication of what's possible when we align execution around the right priorities," referencing new operational initiatives and improvements in customer relationships as key contributors. This marked the company’s strongest quarterly and annual organic growth rate since 2018, with notable gains in revenue per customer.
Looking ahead, Proto Labs’ guidance reflects expectations for continued momentum as management executes on a multi-year transformation strategy. The company is focused on elevating the customer experience, accelerating innovation, and expanding production capabilities—particularly in the medical and aerospace sectors. Krishna described 2026 as “a year of transformation and growth focused on execution,” citing new certifications in injection molding, the launch of customer-facing platforms, and investments in global engineering talent. While management sees a credible path to double-digit revenue growth over time, CFO Dan Schumacher cautioned that operating margin expansion may be limited in the near term as resources are reallocated to fund these initiatives.
Management highlighted the impact of strategic operational changes, product capability expansions, and focused market penetration as key drivers of the quarter’s growth and improved profitability.
Proto Labs’ outlook is shaped by targeted investments in customer experience, production capabilities, and operational efficiency, with growth expected to be supported by expansion in key verticals.
Going forward, our analysts will be tracking (1) the pace of adoption for new customer experience initiatives like ProDesk and their effect on conversion and retention, (2) progress in scaling production programs with medical and aerospace customers following recent certifications, and (3) the impact of operational restructuring in Europe and the buildout of the India capability center. Continued innovation in manufacturing capabilities and execution on digital transformation will also be key markers of Proto Labs’ ability to sustain momentum.
Proto Labs currently trades at $65.29, up from $52.48 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
| 7 hours | |
| Feb-13 | |
| Feb-13 | |
| Feb-13 | |
| Feb-12 | |
| Feb-12 | |
| Feb-10 | |
| Feb-07 | |
| Feb-06 | |
| Feb-06 | |
| Feb-06 | |
| Feb-06 | |
| Feb-06 | |
| Feb-04 | |
| Jan-27 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite